Back to Top ↑Symposium Sessions |
| Monday June 29 |
| 10:30 | Materials for Drug & Gene Delivery |
| Tuesday June 30 |
| 8:30 | Biotech & Medicine Keynotes |
| 1:30 | Nanomedicine, Drug and Gene Delivery: Challenges & Results Discussion Panel |
| 4:00 | Nanomedicine - Posters |
|
Symposium Program |
| Monday June 29 |
|
| 10:30 | Materials for Drug & Gene Delivery | |
| Session chair: Puneet Tyagi, AstraZeneca, Jeannine M. Coburn, Worcester Polytechnic Institute |
| Particle-based drug delivery systems:role of pharmaceutical development
J. Rashba-Step, Phosphorex, Inc., US |
| Delivery of mRNA vaccines by lipid nanoparticles
K. Hassett, Moderna Therapeutics, US |
| Examining and exploiting lymphatic vessels for drug delivery at mucosal surfaces
K. Maisel, University of Maryland, US |
| TBA
M. Dobrovolskaia, National Cancer Institute, US |
| Pearl Bio - Templated Biomaterials for Half-Life Extension and Therapeutic Functionalization
N. Ma, Yale University, US |
| Tuesday June 30 |
|
| 8:30 | Biotech & Medicine Keynotes | |
| Artery-on-a-chip for pressure myography
A.M. Clyne, University of Maryland, US |
| Janus Base Nanopieces for RNA and Small Molecule Drug Delivery
Y. Chen, University of Connecticut, US |
| Preventing Global Pandemics with Gene Therapy Approaches
L. Santos, AstraZeneca, US |
| CRISPR Powered Transistors: Harnessing Biology as Technology
K. Aran, Keck Graduate Institute, US |
|
| 1:30 | Nanomedicine, Drug and Gene Delivery: Challenges & Results Discussion Panel | |
| Session chair: Maggie Scully, NIH/NCI, US |
| Preclinical Studies for Nanoparticle-Enabled Photothermal Therapy: Progress and Challenges
L. Pagliaro, Siva Therapeutics Inc., US |
| T.J. Webster, Northeastern University, US |
| M.A. Dobrovolskaia, National Cancer Institute, US |
| L. Santos, AstraZeneca, US |
| J. Rashba-Step, Phosphorex, Inc., US |
| T. Anchordoquy, University of Colorado, US |
| L. Pagliaro, Siva Therapeutics Inc., US |
|
| 4:00 | Nanomedicine - Posters | |
| Recent Advances in Cancer Stem Cell-Targeted Immunotherapy.
S.Y. Yoo, Pusan National University, KR |
| Immune Checkpoint Inhibitor Nanocomposites for Pulmonary Metastatic Colorectal Cancer.
S.Y. Yoo, Pusan National University, KR |
| A Cancer-Favoring, Engineered Vaccinia Virus for Cholangiocarcinoma.
S.Y. Yoo, Pusan National University, KR |
| Lysozyme enriched tyrosine surface protected gold nanoparticles: Potent antimicrobials against multi-drug resistant bacteria
A. Umapathi, H.K. Daima, Amity University Rajasthan, IN |
| Isonicotinylhydrazide on epigallocatechin gallate-protected gold nanoparticles: Toxicity management and stability enhancement
A. Umapathi, H.K. Daima, Amity University Rajasthan, IN |
| Will Nanocarbon Onion-Like Fullerenes (NOLFs) Play a Decisive Role in the Future of Molecular Medicine? NOLF 4: An Alternate View of Fullerene Material’s Antioxidant Activity.
D.J. Bourassa, Einstein Medical Institute, University of Science, Arts, and Technology, US |
| Exploring Bacterial Interactions of Expanded-PTFE in the Presence of PVP-coated Silver Nanoparticles, Peptides p753 and p359 in 2D and 3D models
M. Finkle, P.M. Navarro, K. Vig, University of Nevada-Las Vegas, US |
| Plants Extract Induced Synthesis of some Metals Nanoparticles and Their Performance as Antimicrobial Agents
O.P. Yadav, CCS Haryana Agricultural University, IN |
| Homodimeric SPECT Scintigraphy Radioligand for Imaging Traumatic Brain Injury Induced Amyloid Plaques
G. Mann, A. Kaul, M. Thirumal, A.K. Mishra, A. Datta, University of Delhi, IN |
| Antimicrobial Alginate Scaffold Model Development against Staphylococcus aureus
P. Melendez Navarro, M. Finkle, S.U. Ahmed, K. Vig, Alabama State University, US |
| Investigation of the antibacterial effects of silver nanolayers on the hard contact lenses coating after a two-year period
K. Koev, N. Donkov, H. Naidenski, T. Nurgaliev, L. Avramov, Institute of Electronics “Acad. Emil Djakov”, Bulgarian Academy of Sciences, BG |
| Enteric Capsules Filled with Everolimus Nanocomposites to Treat Colorectal Cancer
V. Palanirajan, M. Abdelmahmoud, A. Maki, S-C Cheah, UCSI University, MY |
| Study of therapeutic targeting of Tumor Necrosis Factor-alpha(TNF-α) in Lymphocytes and Macrophages by using nanoparticles for limiting Coronary Artery Disease (CAD)*
R. Shabbir, A. Raza, A. Liaquat, S. Shah, M. Hamza, M. Fayyaz, Z. Hussain, N.M. Butt, Preston University Kohat,, PK |
|
Preclinical Studies for Nanoparticle-Enabled Photothermal Therapy: Progress and Challenges
Marina A. Dobrovolskaia
Preventing global Pandemics with gene therapy approaches
Delivery of mRNA vaccines by lipid nanoparticles
